
|Articles|March 1, 2003
Intrastromal corneal inlays offer hope for hyperopia
Orlando-Synthetic keratophakia may offer a safe and effective method for refractive correction, according to the interim fol-low-up data from an FDA trial evaluating a hydrogel intrastromal corneal inlay (PermaVision, Anamed)-plus data on the procedure from outside the United States.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Study identifies 6 key genes linking air pollution to dry eye disease
3
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
4
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
5


















































.png)


